{"prediction": {"id": "77e3b09c-e85d-5557-8dd7-eb02ad338729", "work_id": "dacbbc93-d5f0-5454-a310-28e48482f0c3", "study_id": "cfdf56de-1df0-5719-a908-ba73698acba4", "kind": "Model evaluation", "pages": [4], "version": "Version of record", "source_work_id": "dacbbc93-d5f0-5454-a310-28e48482f0c3", "title": "High expression of VISTA on M-MDSCs is associated with immunosuppression and predicts poor prognosis in acute myeloid leukemia.", "doi": "10.1038/s41598-026-61717-x", "pdf_sha256": "5022a5d840517938bab4e91ffc87e160863f6658e8bfa1c9118592be0583e0b4", "physical_page_count": 10}, "fields": {"concrete_comparator": {"value": "higher versus lower VISTA-positive M-MDSC frequency strata in the clinical follow-up cohort", "source_basis": "original_pdf_review", "pages": [4]}, "metric": {"value": "fraction", "source_basis": "original_pdf_review", "pages": [4]}, "population": {"value": "human_observations", "source_basis": "verified_profile", "pages": [1, 3, 4]}, "reference_type": {"value": "observed_clinical_reference", "source_basis": "verified_profile", "pages": [4]}, "reported_time_window": {"value": "three-year clinical outcome evaluation for the specified risk strata", "source_basis": "original_pdf_review", "pages": [4]}, "scenario": {"value": "retrospective_cohort_grouping", "source_basis": "verified_profile", "pages": [4]}}, "endpoints": [{"term": "clinical_events", "label": "Clinical events and scales"}, {"term": "survival", "label": "Survival and mortality"}], "validations": [{"id": "52dc8374-09f1-5e53-a66c-f7eb0f88dd29", "claim_id": "77e3b09c-e85d-5557-8dd7-eb02ad338729", "coverage": "direct_comparison", "support": "supports", "source": "same_source", "overlap": "overlap", "comparability": "matched", "statistics": "significant", "anchors": [{"work_id": "dacbbc93-d5f0-5454-a310-28e48482f0c3", "version": "Version of record", "pages": [4]}]}], "model_resources": {"total": 0, "page": 1, "limit": 50, "rows": [], "review_status": "indexed_source"}}